Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Herombopag for senile primary immune thrombocytopenia and is currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Herombopag | Phase 2 | Status: RECRUITING